APA (7th ed.) Citation

Yongkuan Guo, Ran Zhang, Yiran Meng, Li Wang, Liuqing Zheng, & Jian You. (2024). Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yongkuan Guo, Ran Zhang, Yiran Meng, Li Wang, Liuqing Zheng, and Jian You. Case Report: Durable Response of Ensartinib Targeting EML4-ALK Fusion in Osimertinib-resistant Non-small Cell Lung Cancer. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Yongkuan Guo, et al. Case Report: Durable Response of Ensartinib Targeting EML4-ALK Fusion in Osimertinib-resistant Non-small Cell Lung Cancer. Frontiers Media S.A., 2024.